Skip to content
ChickenStockChickenStock
Research397030
AprilBio logo

AprilBio (397030) stock

KOSDAQ · Pharmaceuticals

KRW 11,880-1.90%(-230)

As of Nov 16, 9:31 AM KST

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 16, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

-37.83x

Net loss — not comparable

P/B

3.38x

P/S

247.86x

Earnings

Revenue, operating profit and net income from periodic reports filed with DART, Korea’s regulatory filing system.

Quarters and year-to-date
PeriodRevenueOperating profitNet incomeRevenue YoY
Q2 2026Separate · Filed Aug 13, 2026—-KRW 2.9 billion-KRW 2 billion—
Q1 2026Separate · Filed May 15, 2026KRW 700 million-KRW 2.2 billionKRW 200 million-66.6%
Q3 2025Separate · Filed Nov 13, 2025—-KRW 2.5 billion-KRW 5 billion—
Q2 2025Separate · Filed Aug 13, 2025—-KRW 2.7 billion-KRW 3.1 billion—
Q1 2025Separate · Filed May 15, 2025KRW 2.2 billion-KRW 100 millionKRW 600 million—
Q3 2024Separate · Filed Nov 14, 2024—-KRW 2.4 billion-KRW 3.1 billion—
Fiscal years
PeriodRevenueOperating profitNet incomeRevenue YoY
FY2025Separate · Filed Mar 13, 2026KRW 2.2 billion-KRW 7.3 billion-KRW 9.7 billion-92.1%
FY2024Separate · Filed Mar 13, 2025KRW 27.5 billionKRW 16.9 billionKRW 20 billion—
  • Q2 2026 is computed as H1 2026 minus Q1 2026.
  • Q3 2025 is computed as 9M 2025 minus H1 2025.
  • Q2 2025 is computed as H1 2025 minus Q1 2025.
  • Q3 2024 is computed as 9M 2024 minus H1 2024.
Original filing (DART)

Short selling and securities lending

Short sales as a share of trading value, the reported short position and the securities lending balance.

Short-sale share
2.80%
Of trading value on Nov 13, 2026
Short-sale value
KRW 90 million
Previous 20-day average 8.31%
Net short position
13,000 shares
As of Nov 11, 2026 · reported with a two-trading-day lag
Lending balance
1,942,906 shares
As of Nov 13, 2026 · 7.05% of listed shares
Recent short-sale days
DateShareValue
Nov 13, 20262.80%KRW 90 million
Nov 12, 20268.04%KRW 190 million
Nov 11, 20269.25%KRW 260 million
Nov 10, 20265.71%KRW 130 million
Nov 9, 20265.55%KRW 170 million
Nov 6, 202615.43%KRW 490 million
Nov 5, 202616.10%KRW 570 million
Nov 4, 202610.11%KRW 270 million
Nov 3, 202617.90%KRW 400 million
Nov 2, 20263.64%KRW 50 million

The short-sale share is short-sale value divided by total trading value that day. The lending balance also includes stock lent for purposes other than short selling.

AprilBio (397030) stock information

KOSDAQ

AprilBio (397030) is listed on KOSDAQ. Its market capitalization is about KRW 327.4 billion. On trailing-twelve-month earnings the P/E ratio is -37.83, and the P/B ratio is 3.38. Return on equity is -8.9%. These figures are computed in-house from official filings and are reference information only.

AprilBio — frequently asked questions

What is the P/E ratio of AprilBio (397030)?
On a trailing-twelve-month basis, 397030 trades at a P/E ratio of -37.83. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of AprilBio?
397030 has a market capitalization of about KRW 327.4 billion. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.